Literature DB >> 23128973

Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation.

Xiaolei Shao, Zhijun He, Luosheng Tang, Ling Gao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23128973     DOI: 10.1097/TP.0b013e31826dde21

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Bilateral Inflammatory Optic Neuropathy Related to Graft versus Host Disease Following Allogeneic Bone Marrow Transplantation for Hodgkin Disease.

Authors:  I Moesen; D P Kidd
Journal:  Neuroophthalmology       Date:  2014-07-22

2.  Tacrolimus Optic Neuropathy Mimicking Papilledema.

Authors:  Isra M Hussein; Jonathan A Micieli
Journal:  Case Rep Ophthalmol       Date:  2022-05-10

3.  A case of reversible toxic optic neuropathy from tacrolimus (FK506).

Authors:  Kimberly K Gokoffski; Vivek R Patel
Journal:  Am J Ophthalmol Case Rep       Date:  2020-09-16

4.  Tacrolimus induced optic neuropathy in post-lung transplant patients: A series of 3 patients.

Authors:  Tavish Nanda; Nailyn Rasool; Srilaxmi Bearelly
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-11

Review 5.  Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.

Authors:  Sheng Chen; Jun Hu; Liang Xu; Dixon Brandon; Jun Yu; Jianmin Zhang
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

Review 6.  Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review.

Authors:  Turun Song; Zhengsheng Rao; Qiling Tan; Yang Qiu; Jinpeng Liu; Zhongli Huang; Xianding Wang; Tao Lin
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

7.  Did you choose appropriate tracer for retrograde tracing of retinal ganglion cells? The differences between cholera toxin subunit B and Fluorogold.

Authors:  Fei Yao; Endong Zhang; Zhaolin Gao; Hongpei Ji; Mahmoud Marmouri; Xiaobo Xia
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.